Clearance Summary
VIOLA received FDA 510(k) clearance under submission number K230248, sponsored by Vascular Graft Solutions, Ltd.. The device was reviewed via the Special premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2023-02-28.
- Submission: K230248
- Applicant / Sponsor: Vascular Graft Solutions, Ltd.
- Clearance pathway: Special
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.4450
- Decision date: 2023-02-28
Classification & Regulation
This clearance is catalogued under FDA product code DXC and 21 CFR 870.4450, within the Cardiovascular review panel as a Class II device.